Communication
Structural and Mechanistic Basis of the Interaction between a Pharmacological Chaperone and Human Phenylalanine Hydroxylase
Article first published online: 30 APR 2012
DOI: 10.1002/cbic.201200188
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Torreblanca, R., Lira-Navarrete, E., Sancho, J. and Hurtado-Guerrero, R. (2012), Structural and Mechanistic Basis of the Interaction between a Pharmacological Chaperone and Human Phenylalanine Hydroxylase. ChemBioChem, 13: 1266–1269. doi: 10.1002/cbic.201200188
Publication History
- Issue published online: 13 JUN 2012
- Article first published online: 30 APR 2012
- Manuscript Received: 19 MAR 2012
Funded by
- Fundación Agencia Aragonesa para la Investigación y el Desarrollo (ARAID, Spain)
- Ministerio de Ciencia e Innovación (MICINN, Spain). Grant Numbers: BFU2010-19504, BFU2010-16297
- Grupo Protein Targets B89
Keywords:
- folding mechanisms;
- pharmacological chaperones;
- phenylalanine hydroxylases;
- phenylketonuria

Not without a chaperone: Pharmacological chaperones are designed to bind and ideally stabilise their target protein. Here, we elucidate the molecular mechanism of a potential pharmacological chaperone to treat phenylketonuria. The crystal structure of human phenylalanine hydroxylase with compound IV may help in the rational design of more efficient compounds to treat this disease.

1439-7633/asset/2268_left.gif?v=1&s=307233408e54255dc0d91f8b45dbcbc9d91c02fb)
1439-7633/asset/2268_right.gif?v=1&s=3d91b10da22cd11de4d8c9a972145ff16791ee1f)
